RenovoRx, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
RNXT on Nasdaq
Location
333 W. Santa Clara Street, Suite 900, San Jose, CA

There are no Buy or Sell transactions made by insiders since 12/22/2023

RenovoRx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kamran Najmabadi 10%+ Owner $1.03M Aug 25, 2021
Bank Of The West 10%+ Owner $1.02M Mar 16, 2022
Shaun Bagai Chief Executive Officer, Director $306K Jan 26, 2024
Ramtin Agah Chief Medical Officer, Director $49.6K Jan 26, 2024
Robert J. Spiegel Director $42.8K Oct 1, 2024
Macfarlane K. Angela Director $42.8K Oct 1, 2024
Laurence Marton Director $35.1K Oct 1, 2024
Paul Manners Chief Financial Officer $24.4K Aug 25, 2021
Angela Nelms Chief Operating Officer $1.15K Jan 19, 2024
Ron Kocak VP, Controller and PAO Feb 9, 2024
Leesa Gentry Chief Clinical Officer Mar 6, 2024
David Diamond Director Oct 1, 2023
Christopher J. Lehman Chief Financial Officer Aug 30, 2021
James M. Ahlers Chief Financial Officer Jul 15, 2022
Una S. Ryan Director Oct 1, 2024

Recent Insider Transactions by Companies or Individuals for RenovoRx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.